within Pharmacolibrary.Drugs.ATC.C;

model C08CA04
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.328,
    Cl             = 0.66 / 1000 / 60,
    adminDuration  = 600,
    adminMass      = 30 / 1000000,
    adminCount     = 1,
    Vd             = 0.0018,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.008333333333333333,
    Tlag           = 10.020000000000001
  );

  annotation(Documentation(
    info ="<html><body><p>Nicardipine is a dihydropyridine calcium channel blocker used in the management of hypertension and angina pectoris. It works primarily by relaxing vascular smooth muscle, thus dilating blood vessels to reduce blood pressure. Nicardipine is approved and widely used for acute hypertension, including hypertensive emergencies and for short-term management of high blood pressure.</p><h4>Pharmacokinetics</h4><p>Healthy adult volunteers, single oral administration.</p><h4>References</h4><ol><li><p>Jung, YH, et al., &amp; Kim, JH (2022). Effect of concomitant oral administration of ethanol on the pharmacokinetics of nicardipine in rats. <i>Biomedical chromatography : BMC</i> 36(9) e5425–None. DOI:<a href=&quot;https://doi.org/10.1002/bmc.5425&quot;>10.1002/bmc.5425</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/35696664/&quot;>https://pubmed.ncbi.nlm.nih.gov/35696664</a></p></li><li><p>Piao, YJ, &amp; Choi, JS (2008). Effects of morin on the pharmacokinetics of nicardipine after oral and intravenous administration of nicardipine in rats. <i>The Journal of pharmacy and pharmacology</i> 60(5) 625–629. DOI:<a href=&quot;https://doi.org/10.1211/jpp.60.5.0008&quot;>10.1211/jpp.60.5.0008</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/18416939/&quot;>https://pubmed.ncbi.nlm.nih.gov/18416939</a></p></li><li><p>Choi, JS, &amp; Burm, JP (2009). Effects of oral epigallocatechin gallate on the pharmacokinetics of nicardipine in rats. <i>Archives of pharmacal research</i> 32(12) 1721–1725. DOI:<a href=&quot;https://doi.org/10.1007/s12272-009-2209-7&quot;>10.1007/s12272-009-2209-7</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/20162400/&quot;>https://pubmed.ncbi.nlm.nih.gov/20162400</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end C08CA04;
